Microbiota Engraftment

Demonstration of microbiota engraftment was central to the new terminology of what was formerly known by various names, e.g., fecal bacteriotherapy, to ‘Fecal Microbiota Transplantation’. The term was first used in a December 2011 publication link:...

Treatment of fulminant C. difficile infection

The FMT protocol for treatment of fulminant C. difficile infection was published in the Journal of Clinical Gastroenterology in September of 2013. Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share...

FMT to IMT

We renamed the treatment of FMT to IMT Intestinal Microbiota Transplantation’, published in the American Journal of Gastroenterology in 2019. Click here. Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new...

1st Capsule Treatment

The first treatment with capsule preparation of freeze-dried microbiota was done in January 2015. Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to email...

Enforcement Discretion Policy

The FDA announced the enforcement discretion policy with respect regulation of FMT. This policy allows physicians use of FMT in treatment of C. difficile infections that do not respond to standard therapies without federal regulatory oversight. Share this:Click to...
© 2020 Regents of the University of Minnesota. All rights reserved. The University of Minnesota is an equal opportunity educator and employer. Privacy Statement